PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,978.00
Bid: 1,983.00
Ask: 1,984.00
Change: -5.00 (-0.25%)
Spread: 1.00 (0.05%)
Open: 1,983.00
High: 1,991.00
Low: 1,971.00
Prev. Close: 1,983.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sports Direct to drop out of FTSE 100 in reshuffle

Wed, 02nd Mar 2016 17:37

* WM Morrison, Paddy Power and Betfair to join FTSE 100

* Informa and Mediclinic to also join FTSE 100

* Sports Direct, Aberdeen AM, Smiths, Hikma drop out

* Changes will take effect on March 21

By Sudip Kar-Gupta

LONDON, March 2 (Reuters) - Sports Direct andAberdeen Asset Management will drop out of Britain'sbenchmark FTSE 100 equity index after a slump in theirshare prices since the start of 2016.

Other companies to be relegated from the top British sharesindex will be diversified engineering company Smiths Group and Hikma Pharmaceuticals, the London StockExchange said on Wednesday.

Those four companies will be replaced in the FTSE 100 bygambling company Paddy Power Betfair, supermarketoperator WM Morrison, publishing company Informa and private hospital operator Mediclinic International.

Getting into the FTSE 100 can often fuel further demand fora company's shares, since funds that track the FTSE or invest inthe index can then add that stock to their portfolio, while theinverse is true if a company falls out of the FTSE 100.

Sportswear retailer Sports Direct, founded and majorityowned by billionaire Mike Ashley, had been impacted byallegations over the treatment of staff in Britain and a profitwarning. Sports Direct shares have 27 fallen percent since thestart of 2016.

In December, Sports Direct responded to critics of itsemployment practices with the launch of a review of conditionsfor its thousands of agency warehouse workers.

Aberdeen Asset Management's shares have also fallen around10 percent since the start of 2016, with the fund managementcompany hit by a slump in emerging markets.

The rankings are decided on market capitalisation. Companieswith the lowest market cap in the FTSE 100 drop into the FTSE250 mid-cap index, and vice versa.

The changes will take effect on March 21. (Reporting by Sudip Kar-Gupta; Editing by Danilo Masoni)

More News
6 Aug 2021 12:07

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

Read more
6 Aug 2021 09:03

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

Read more
6 Aug 2021 08:40

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

Read more
6 Aug 2021 07:42

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

Read more
6 Aug 2021 07:22

Hikma lifts FY generics guidance as first-half profits, revenue jump

(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.

Read more
30 Jul 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
14 Jul 2021 19:38

IN BRIEF: Arecor ends first half of 2021 with solid cash position

IN BRIEF: Arecor ends first half of 2021 with solid cash position

Read more
13 Jul 2021 10:00

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

Read more
1 Jul 2021 09:51

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

Read more
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more
30 Apr 2021 17:01

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

Read more
30 Apr 2021 08:58

TOP NEWS: Hikma Pharma confident after promising start to year

TOP NEWS: Hikma Pharma confident after promising start to year

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.